Avoiding Loan Forgiveness Is No Shield from False Claims Act Liability in Latest Paycheck Protection Program Fraud Settlement
Client Alert | 2 min read | 04.23.21
On April 21, 2021, the Department of Justice (DOJ) inked its second civil settlement resolving allegations of fraud involving loans issued pursuant to the Paycheck Protection Program (PPP). Sandeep S. Walia, M.D., a Professional Medical Corporation (Walia PMC), and its owner, Dr. Walia, agreed to pay $70,000 in damages and penalties to resolve alleged violations of the False Claims Act (FCA) tied to allegations that Dr. Walia falsely certified in a second PPP loan application that his medical practice had not previously received a PPP loan after it had already received one from a different lender. Walia PMC also agreed to repay the second PPP loan for $430,000. This latest settlement is a continued reflection of the heightened scrutiny of the PPP, and suggests that the FCA may quickly become a favored enforcement tool by the government in its continued pursuit of PPP-related fraud.
Notably, the fact that Walia PMC did not seek forgiveness for the second PPP loan did not shield it from FCA liability. The DOJ’s FCA theory rested on the allegation that Dr. Walia caused a false statement to be made to the SBA when the second lender applied to the SBA to request a loan guaranty for its PPP loan to Walia PMC. In doing so, Walia caused the second lender to falsely represent to the SBA that Walia PMC had not received another PPP loan based on Walia PMC’s certification. This misrepresentation caused the SBA to guarantee the loan and pay the bank in New Jersey a fee of $12,900 for processing the $430,000 PPP loan. The DOJ highlighted that the false statement caused a false claim to be made to the SBA for “processing fees.” The DOJ also emphasized that Walia PMC’s false statement resulted in a reduction of PPP loan funding available for other eligible recipients, commenting: “The second PPP loan should have been disbursed to another small business suffering financially during the COVID-19 pandemic.”
As previously discussed in our analysis of the DOJ’s first civil settlement earlier this year, and as reflected in Assistant Attorney General Brian M. Boynton’s February 2021 remarks, this settlement reinforces that pandemic-related fraud is at the top of the Civil Division’s enforcement priorities for 2021. In fact, this settlement demonstrates that DOJ will not hesitate to utilize the FCA even for relatively smaller loans, a sign that those receiving larger loans approaching the $10 million cap should anticipate potential scrutiny. It also shows that the DOJ will not wait for companies to pursue forgiveness before pursuing FCA enforcement actions.
Contacts
Insights
Client Alert | 2 min read | 02.03.26
CMS Doubles Down on RADV Audit Changes
On January 27, 2026, the Centers for Medicare and Medicaid Services (CMS) released a Health Plan Management System (HPMS) memo that provided a long-awaited update on how the agency plans to approach previously announced Risk Adjustment Data Validation (RADV) audits for Payment Years (PY) 2020-2024. The memo is the agency’s most comprehensive statement on the subject since September 25, 2025, when the Northern District of Texas vacated the 2023 RADV Final Rule. The memo makes clear that, while CMS has made certain operational adjustments in response to concerns expressed by Medicare Advantage Organizations (MAOs), the agency is largely pressing forward with the accelerated audit strategy announced in May 2025.
Client Alert | 2 min read | 02.03.26
Sedona Model Jury Instructions for DTSA: A Step Forward—But Questions Remain
Client Alert | 7 min read | 01.30.26
CMS Proposes CY 2027 Growth Rate and Changes to Risk Adjustment for Medicare Parts C and D
Client Alert | 4 min read | 01.30.26
Optimum’s Shot Across the Bow: An Antitrust Challenge to Cooperation Agreements



